San Francisco, CA, June 17, 2014 --(PR.com
)-- William Baum, Executive Chairman and Chief Business Development Officer of Genomatica, will give a featured presentation titled, “Strategies for Producing and Using Biobased Chemicals”, at the 5th Biobased Chemicals Commercialization & Partnering Conference to be held on September 18-19, 2014 in San Francisco, CA.
Commercial technology is starting to be available for the biobased production of major, high-volume basic and intermediate chemicals. A good example is Genomatica’s GENO BDO™ process for the production of 1,4-butanediol (BDO), which has a market of over 1.6 million metric tons per year and which has been licensed by BASF and Novamont. Two important implications are that chemical producers are beginning to have practical, economic alternatives to petroleum-based processes – for the chemicals they already produce – and that chemical users in numerous value chains are beginning to have a realistic way to increase the biobased content of products they already make without changing their characteristics or their production process. This presentation will summarize key issues for producers and users as they build their strategy for biobased chemicals. It draws from Genomatica’s experience working with numerous value chain partners for biobased BDO, as well as with strategic partners ENI/Versalis and Braskem in developing a process for biobased butadiene.
This two-day conference brings together top representatives who are engaged in establishing a major transformation in the global chemical and energy industries from petroleum to biobased. The conference will look to examine new supply chain developments and business models being adopted for biobased chemicals products. Topics covered include novel chemical production platforms, advantageous feedstock, securing funding and strategic partnerships, trends and challenges in commercial scale up, end user applications, and consumer products. Renewable chemical companies, biofuel companies and end-market consumers will be discussing innovations in the science, technology and end-market development of biobased chemicals, polymers and plastics.
Sessions for 2014 Agenda:
I. Novel Technologies & Platforms in Biochemical Production
II. Advantageous Feedstock for Biochemical Commercialization
III. Panel Discussion: Funding Opportunities
IV. Strategic Partnerships
V. Panel Discussion: Strategic Partnerships
VI. Panel Discussion: The Role of Government in Commercializing Biochemicals
VII. End User Applications & Consumer Products
For more information, please visit www.gtcbio.com/biobasedchemicals